Response Genetics raises $8.8M in financing

Response Genetics (RGDX) announced that it has entered into a purchase agreement with GlaxoSmithKline (GSK) and one of its existing significant stockholders to raise $8.8M from the private placement of 8,000,000 newly issued shares of its common stock at a purchase price of $1.10 per share. The signing of the purchase agreement and closing of the financing occurred today, Thursday, September 13.

View Comments (0)